U.S. markets open in 3 hours 22 minutes
  • S&P Futures

    4,518.75
    -9.25 (-0.20%)
     
  • Dow Futures

    35,389.00
    -88.00 (-0.25%)
     
  • Nasdaq Futures

    15,357.25
    -20.25 (-0.13%)
     
  • Russell 2000 Futures

    2,279.40
    -8.10 (-0.35%)
     
  • Crude Oil

    82.80
    -0.62 (-0.74%)
     
  • Gold

    1,788.10
    +3.20 (+0.18%)
     
  • Silver

    24.34
    -0.10 (-0.43%)
     
  • EUR/USD

    1.1643
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.6360
    0.0000 (0.00%)
     
  • Vix

    15.96
    +0.26 (+1.66%)
     
  • GBP/USD

    1.3798
    -0.0028 (-0.20%)
     
  • USD/JPY

    114.0300
    -0.2990 (-0.26%)
     
  • BTC-USD

    66,153.62
    +2,187.62 (+3.42%)
     
  • CMC Crypto 200

    1,564.85
    +84.05 (+5.68%)
     
  • FTSE 100

    7,199.42
    -23.68 (-0.33%)
     
  • Nikkei 225

    28,708.58
    -546.97 (-1.87%)
     

Why Mirati Therapeutics Is A Dangerous Rival To Amgen In Colon Cancer

·2 min read
Why Mirati Therapeutics Is A Dangerous Rival To Amgen In Colon Cancer
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Mirati could beat Amgen to market with a KRAS-blocking colon cancer drug, an analyst said Monday as MRTX stock popped.